
Join to View Full Profile
UCSF Sch of MedSan Francisco, CA 94101
Dr. Appa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of California San Francisco School of MedicineClass of 2013
Certifications & Licensure
- CA State Medical License 2018 - 2025
- WA State Medical License 2014 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- American Board of Preventive Medicine Addiction Medicine
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- Harm Reduction Contingency Management for Stimulant Use Reduction and Antiretroviral Therapy Adherence in HIV Primary Care: Protocol for an Implementation Effectivenes...Gabriela Steiner, Stefan Baral, Elise D Riley, Steven Shoptaw, Gabriel Chamie
JMIR Research Protocols. 2025-08-18 - 4 citationsHigh Retention and Adherence With Rapid Long-acting Injectable Preexposure Prophylaxis Implementation in an Urban Safety Net Clinic Population.Matthew A Spinelli, Ezra Bisom-Rapp, Megan J Heise, Christina Camp, Ayesha Appa
Clinical Infectious Diseases. 2025-06-04 - 13 citationsViral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial Viremia.Matthew D Hickey, Nathanael Gistand, Janet Grochowski, Francis Mayorga-Munoz, Elizabeth Imbert
Clinical Infectious Diseases. 2025-04-30
Press Mentions
- UCSF Doctors Warn: Abstinence-Only Approach to Drug Use Can KillMarch 26th, 2025
- Overdose Deaths Have Reduced Survival Gains Among People with HIV in British ColumbiaJuly 20th, 2020
Grant Support
- Taking Our Shot: Extended-Release Naltrexone as Opioid Overdose Pre-Exposure Prophylaxis (PrEP) in People Using Stimulants Living With or At Risk of HIVUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: